Pharmacy Times
JULY 10, 2025
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses how oncology pharmacists can lead value-based care efforts under the Enhanced Oncology Model (EOM) by improving care coordination, managing costs, aligning with performance metrics, and leveraging clinical data systems to enhance patient outcomes.
European Pharmaceutical Review
JULY 10, 2025
Traditional testing has relied upon an elegant biological system: horseshoe crab blood contains specialised cells that clot when exposed to endotoxins. This natural defence mechanism, refined over millions of years of evolution, forms the basis of Limulus Amebocyte Lysate testing. When LAL reagent encounters endotoxins, it triggers a cascade reaction leading to gel formation, cloudiness, or colour changes depending on the detection method employed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 10, 2025
An expert discusses how pharmacists can overcome common vaccination barriers by addressing misconceptions about vaccine necessity, making strong provider recommendations, and educating patients about mild adverse effects while building trust through consistent communication.
Pharma Times
JULY 10, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Osivax publishes phase 2a results supporting dual flu vaccine approach by John Pinching | 10th Jul 2025 | News OVX836 shown to be safe and effective alongside seasonal Fluarix Tetra Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, OVX836, can be safely co-admin
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
PharmaVoice
JULY 10, 2025
ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from a patient perspective.
Pharmacy Times
JULY 10, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Times
JULY 10, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
pharmaphorum
JULY 10, 2025
Rich Cooper, CEO of Datapharm, shares his insight on what HCPs need from the pharmaceutical industry to improve access to reliable, trusted medicines information.
Pharmacy Times
JULY 10, 2025
Annie Eisenbeis, PharmD, MBA, showcased how Missouri’s Pharmacy Vaccine Gap Closure Program is transforming pharmacy-based immunization services through scalable workflows, team training, and a redefined role for pharmacy technicians as community health workers.
Pharmaceutical Technology
JULY 10, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 10, 2025
Lara Zakaria, PharmD, introduced the topic of pharmaconutrition, urging pharmacists to integrate food, lifestyle, and gut health into patient care through evidence-based, practical interventions.
Pharma Times
JULY 10, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Government to adopt EU standards for high-risk diagnostic devices by John Pinching | 10th Jul 2025 | News New regulations aim to simplify processes and strengthen patient safety The Government is set to amend UK medical devices regulations by adopting EU Common Specifications for high-risk in vitro diagnostic
Pharmacy Times
JULY 10, 2025
An expert discusses how pharmacists can evaluate patients with prior adverse vaccine reactions by distinguishing between mild local reactions and serious anaphylactic responses, then recommending supervised vaccination or medical center administration when appropriate.
Beckers Hospital Review
JULY 10, 2025
Healthcare access is not just about wait time, according to Baligh Yehia, MD, president of Jefferson Health. The 32-hospital Philadelphia-based system, views the issue of access as a multidirectional problem. More than 3 in 5 Americans cannot access affordable, quality care, according to a 2024 Gallup poll. Complete access to healthcare looks like a low wait time, having the appropriate type of care in a nearby facility, and being treated from a culturally competent perspective, Dr.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmaceutical Technology
JULY 10, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Pharmacy Times
JULY 10, 2025
By closing the gap on patients recommended lipid-lowering therapies who do not receive them, researchers say that thousands of cardiovascular events could be prevented and billions of dollars would be saved.
UWorld | RxPrep
JULY 10, 2025
Boost your pharmacy career with board certification; gain credibility, deliver better patient outcomes, earn more, and open doors to advanced practice roles and specialties.
Pharmacy Times
JULY 10, 2025
An expert discusses how landmark trials such as ASC4FIRST, ENESTnd, and BFORE provide evidence for frontline tyrosine kinase inhibitor (TKI) selection, with asciminib showing superior tolerability and lower discontinuation rates (4.5%) compared with first-generation (11%) and second-generation TKIs (9.8%).
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The Pharmacist
JULY 10, 2025
Pharmacists have been advised to stop supplying one batch of Zaditen 0.25 mg/ml eye drops solution following a precautionary recall issued by the Medicines and Healthcare products Regulatory Agency (MHRA). The recall affects batch number 4V64 (expiry date: 30 September 2026), distributed in 5ml packs. The batch was first distributed on 27 January 2025.
Pharmacy Times
JULY 10, 2025
An expert discusses how achieving molecular and clinical milestones early in chronic myeloid leukemia (CML) treatment reduces transformation risk, enables potential treatment discontinuation after specific criteria are met, and helps identify treatment resistance requiring mutational analysis or adherence assessment.
The Pharmacist
JULY 10, 2025
The Advertising Standards Authority (ASA) has taken action against nine advertisers for promoting weight loss prescription-only medicines (POMs) to the public in breach of UK law and advertising regulations. Six of the offenders are pharmacies registered with the General Pharmaceutical Council (GPhC). ASA emphasised that all injectable forms of weight loss medication are POMs and […] The post ASA takes action against pharmacies breaking rules on weight loss meds appeared first on The Pharm
Pharmaceutical Technology
JULY 10, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
JULY 10, 2025
Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug across 120 low- and lower-middle-income countries over the next three years.
Express Pharma
JULY 10, 2025
Lupin and a pan-European pharmaceutical company, Zentiva have entered into a license and supply agreement for commercialisation of Lupin’s biosimilar Certolizumab Pegol, across multiple markets globally. This alliance aims to accelerate the availability of high-quality, cost-effective biosimilar Certolizumab Pegol to patients worldwide. Lupin will be responsible for the development, manufacturing and supply of the product within the agreed territories.
Pharmaceutical Commerce
JULY 10, 2025
News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &
Pharmaceutical Technology
JULY 10, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Big Molecule Watch
JULY 10, 2025
On June 2, 2025, Sandoz announced that WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are now available to patients in the United States. WYOST® and Jubbonti® are the first and only interchangeable FDA-approved denosumab biosimilars and are approved to treat all indications of the reference medicines, XGEVA® and Prolia®. The FDA approved WYOST® and Jubbonti® on March 5, 2024.
Beckers Hospital Review
JULY 10, 2025
A new analysis has challenged an earlier assessment of the severity and prevalence of withdrawal symptoms following antidepressant use, sparking a renewed debate over long-term mental health treatment strategies. The review, published July 9 in JAMA Psychiatry , included more than 17,000 patients across 50 studies and found that symptoms such as dizziness, nausea and vertigo were all more common in patients who stopped taking an antidepressant compared with those who had been on a placebo, with
Pharmaceutical Business Review
JULY 10, 2025
This application aims to secure approval for treating adult and adolescent atopic dermatitis (AD). Under the partnership agreement, Connect Biopharma will receive up to approximately $110m in milestone payments conditional on reaching specific developmental, regulatory and commercial targets. Additionally, it is expected to earn royalties at tiered percentage rates up to low double-digit percentages on net sales in Greater China Connect Biopharma CEO and director Barry Quart said: “Simcere conti
The Script
JULY 10, 2025
Learn how pharmacy technicians can grow their careers through certifications, specialized experience, and the right job fit. Rx relief is here to help!
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
26 
Let's personalize your content